Californias FAI model, known as Cal MediConnect, was implemented in seven of Californias largest counties and enrolled approximately 113,000 dual eligible beneficiaries as of December 2022
CrossRef A multi-biomarker panel for non-invasive diagnosis, risk stratification, subtype identification, and therapeutic targeting in NAFLD: bioinformatics and experimental insights Kanglong Zhang, Yiming Gan, Yihua Chen, Zhiwei Jiang, Qiao Lei, Shuqin Yu, Linwei Ran, Jie Zheng, Guoxin Hu Biochemical and Biophysical Research Communications .2025
Identification of a major hepatic copper binding protein as S-adenosylhomocysteine hydrolase
Common side effects may include: Nausea Constipation or diarrhea Abdominal cramping Heartburn, reflux, or belching Headaches Fatigue These symptoms often occur within the first 23 days after injection and typically lessen over time
For pH-sensitive hydrazone linker design, introducing different substituents or modulating electronic effects enables precise control over hydrazone linker cleavage rates
